Figure 5. CNAs of PPM1G in LIHC (cBioPortal). (A) OncoPrint plot of PPM1G alterations in the LIHC cohort. The different types of genetic alterations are highlighted in different colors. (B) Correlation between PPM1G expression and CNAs in LIHC. The PPM1G amplification (AMP) group had significantly increased expression. (C) Distribution of PPM1G CNV frequency across different grade subgroups. (D) Distribution of PPM1G CNV frequency across different stage subgroups. The percentage on the right of the bar indicates the proportion of patients with PPM1G gain or AMP in all subgroups of patients. (E) PPM1G CNV affects overall survival.